Clinical Trial Update: NOACs for Stroke Prevention in Patients With Atrial Fibrillation and Previous ICH [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating NOACs for stroke prevention in patients with atrial fibrillation and prior intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Intracerebral Hemorrhage

Snippet

Sponsor: Population Health Research Institute | Conditions: Atrial Fibrillation, Intracerebral Hemorrhage | Phase 2 | Status: COMPLETED